Pacira Pharmaceuticals (PCRX) PT Lowered to $52 at Jefferies
Tweet
Share
E-mail
Get Alerts PCRX Hot Sheet
Price: $23.24 --0%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 22
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 22
Join SI Premium – FREE
Jefferies lowered its price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $52.00 (from $57.00) while maintaining a Buy rating following results.
Analyst David Steinberg trimmed FY17 Exparel revs by $8M to $283M to align with the midpoint of updated guidance.They also trim FY18-20 sales ests by 4-6%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Streamex Corp. (STEX) PT Lowered to $4 at Needham
- KeyBanc Downgrades Kite Realty Group (KRG) to Sector Weight
- Bullish (BLSH) PT Lowered to $45 at Canaccord
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
